Higashi Y, Wakabayashi A, Matsumoto Y, Watanabe Y, Ohno A
Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan.
Chemotherapy. 1999 Jan-Feb;45(1):37-47. doi: 10.1159/000007163.
We have investigated the relationships between the minimum inhibitory concentrations (MICs) of eight beta-lactams and their binding affinities of penicillin binding proteins in low- and high-level methicillin-resistant Staphylococcus aureus (MRSA). For high-level MRSA (H-MRSA), a significant correlation was found between IC50 for PBP2A and MIC, whilst no clear relationship was apparent for low-level MRSA (L-MRSA). However, the product of the IC50s for PBP2A and PBP4 significantly correlated with the MIC in L-MRSA. Since PBP4 is thought to mediate secondary cross-linking of the staphylococcal cell wall, we analyzed the effect on cell wall cross-linking of L- and H-MRSA of two representative drugs (cefoselis and flomoxef). Interestingly, the decrease in cell wall cross-linking, which was clearly observed in L-MRSA, was diminished with H-MRSA. It is concluded that for L-MRSA, a reduction in cell wall cross-linking caused by inhibiton of PBP4 may contribute to the antimicrobial activity of beta-lactam antibiotics, while for H-MRSA, inhibition of PBP2A mainly determines the antimicrobial activity. Since neither alteration of expression nor binding affinity of PBP4 were observed in these studies, unknown factors must operate to diminish the effect of PBP4 inhibition and contribute to the mechanism of high level resistance of MRSA.
我们研究了8种β-内酰胺类药物的最低抑菌浓度(MIC)与耐甲氧西林金黄色葡萄球菌(MRSA)低水平和高水平菌株中青霉素结合蛋白的结合亲和力之间的关系。对于高水平MRSA(H-MRSA),发现PBP2A的IC50与MIC之间存在显著相关性,而对于低水平MRSA(L-MRSA),未发现明显的关系。然而,L-MRSA中PBP2A和PBP4的IC50乘积与MIC显著相关。由于PBP4被认为介导葡萄球菌细胞壁的二级交联,我们分析了两种代表性药物(头孢塞利和氟氧头孢)对L-MRSA和H-MRSA细胞壁交联的影响。有趣的是,在L-MRSA中明显观察到的细胞壁交联减少在H-MRSA中减弱。得出的结论是,对于L-MRSA,抑制PBP4导致的细胞壁交联减少可能有助于β-内酰胺类抗生素的抗菌活性,而对于H-MRSA,抑制PBP2A主要决定抗菌活性。由于在这些研究中未观察到PBP4的表达或结合亲和力的改变,必然存在未知因素来减弱PBP4抑制的作用并促成MRSA高水平耐药的机制。